When Wendy Clift went for a routine breast scan in 2007, she got call from her doctors almost immediately.
Share this @internewscast.com

When Wendy Clift went for a routine breast scan in 2007, she got call from her doctors almost immediately.

“The news wasn’t good,” the widowed grandmother of two from Scone in regional NSW told 9news.com.au.

When Wendy Clift went for a routine breast scan in 2007, she got call from her doctors almost immediately.
Wendy Clift was diagnosed with breast cancer in 2007. (Supplied)

Just days later, she had a mastectomy, followed by more treatment.

While it was successful in keeping her in remission for a few years, the cancer has now returned and it has spread.

However, Clift, now 72, was invited to be part of a new Australian drug trial.

It’s hoped it could help patients with a certain kind of breast cancer live longer.

The DIAmOND clinical trial indicated that introducing dual immunotherapy alongside existing treatments might be beneficial for some patients suffering from advanced HER2-positive breast cancer.

Clift said her cancer appears to be “pretty stable” after the trial earlier this year, which she did at Lake Macquarie Private Hospital.

Some of the cancerous lumps she had have even disappeared, though she doesn’t know if that’s due to the new drug combination.

Clift said she didn’t have side effects.

She said taking part in the trial was less about her and more to help future patients.

“I’m just prepared because whatever happens to me is neither here nor there, but hopefully in years to come it’ll help somebody else,” she said.

Immunotherapy is a treatment that uses a person’s immune system to treat certain cancers.

When Wendy Clift went for a routine breast scan in 2007, she got call from her doctors almost immediately.
Wendy Clift, pictured with son Joshua and grandchildren Florence and Arthur, says she just wants to help future cancer patients. (Supplied)

The other drug used alongside this in the trial was trastuzumab, commonly known as Herceptin.

The trial focused on determining whether the combination could extend the period during which cancer remained controlled in patients with advanced conditions that had developed resistance to trastuzumab.

Results differed depending on the kind of cancer each of the 68 trial patients had.

Some had a response rate of up to 63 per cent, while for other kinds it was 27 per cent.

Some patients saw their cancer controlled for more than two years.

The combination of drugs has been given previously to people with lung cancer.

Professor Sherene Loi developed and led the trial, which was conducted by the research organisation Breast Cancer Trials.

“The encouraging findings imply that pairing new immunotherapy treatments with trastuzumab could provide a new treatment avenue for those with treatment-resistant HER2-positive breast cancer,” Loi stated.

“These findings provide a compelling case for further exploration and how we can best integrate this treatment combination into clinical practice.”

What is HER2-positive breast cancer?

HER2-positive breast cancer is a type of breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2).

However, it often responds well to specific treatments.

Around 15-20 per cent of all types of breast cancers are HER2-positive.

It is more common in younger, pre-menopausal women.

Share this @internewscast.com
You May Also Like
Emergency services were called to a home used as a medical clinic near the corner of Gaffney and Derby streets in Pascoe Vale about 9.30pm yesterday.

A Suspicious Fire Forces Evacuation After Sweeping Through Medical Clinic

An investigation is under way into a suspicious fire that engulfed a…

Israel Aims to Increase Military Forces by 10,000 Amid Draft Dispute

Israeli strikes killed at least 38 people in Gaza as the Palestinian…
There is a new push to ban a popular plant sold at Bunnings Warehouse.

Experts Warn: Popular Product in Australian Nurseries May Be Dangerous

There is a renewed effort to prohibit a popular plant available at…

Police Verify Human Remains Found in Search for Pheobe Bishop, Community Unites

Police have confirmed human remains were found in the search for missing…

Erin Patterson, the Mushroom Cook Under Accusation, Faces a Week on the Witness Stand

Mushroom cook Erin Patterson has confessed to dishonesty, recounted past embarrassments, and…
The Australian icon will hit stage in Adelaide tonight to kick off a solo national tour.

Jimmy Barnes Shares the One Word He Never Uses

From a humble start to famous rocker, Jimmy Barnes has never been…

Family Appeals after Robert Pether’s Bail Release in Iraq

The family of an Australian man jailed in Iraq for four years…
Perth Children's Hospital Foundation hospice

Local Council Criticized for Rejecting Park Proposal for Children with Terminal Illnesses

There’s a small piece of land in Perth’s west causing a significant…
Leannedra Kang and Takahiro Toya were supposed to leave Launceston, Tasmania on a flight to Brisbane on June 4

Queensland Tourists Previously Missing in Tasmania Confirmed Dead by Police

Two tourists who have been missing in Tasmania since Wednesday have been…

Russian Airstrikes Retaliate for Operation Spider’s Web, Leaving Nine Dead in Ukraine

Russian air attacks on Ukrainian cities have claimed the lives of nine…
Victoria Police said five to six armed males were arguing with each other inside CS Square in Caroline Springs about 6:40pm on Friday.

Melbourne Shopping Center Locked Down Due to Machete Threat

A group of boys carrying machetes caused a lockdown at a Melbourne…
Two teenagers have been hospitalised after an alleged stabbing at a family function, after a group of boys crashed the event.

Teens Hospitalized Following Stabbing Incident at Family Event

Two teenagers were taken to the hospital following a stabbing incident that…